Literature DB >> 21102562

Microvesicle-mediated RNA molecule delivery system using monocytes/macrophages.

Yukihiro Akao1, Akio Iio, Tomohiro Itoh, Shunsuke Noguchi, Yuko Itoh, Yoshinori Ohtsuki, Tomoki Naoe.   

Abstract

Microvesicles (MVs) and exosomes, which are shed from cells as a cell-to-cell communication tool, are possible vehicles for navigating RNA molecules to body tissues. It is considered that intravenous injection of such MVs or exosomes from patients would not cause severe not-self and toxic reactions. Previously, we found that macrophages take up liposome-entrapped RNA molecules, some of which remain undegraded in the cells. Here, we demonstrate that transfected RNA molecules in human monocytic leukemia THP-1 cells were shed from THP-1 macrophages as contents in MVs during incubation in serum-free medium, which shedding was shown by biochemical analyses such as quantitative reverse transcription (qRT)-PCR, expression of TSG101 (a membrane-associated exosomal protein), and immunoelectron microscopic study. More chemically modified RNA molecules (miR-143BPs) entrapped by MVs (MV-miR-143BPs) were secreted from THP-1 macrophages after miR-143BP transfection compared with the amount after transfection with nonmodified miR-143 transfection. Furthermore, we show that the THP-1 macrophages, which were transfected with the miR-143BP ex vivo, secreted MV-miR-143BPs in xenografted nude mice after intravenous injection, because miR-143 levels were significantly increased in the serum, tumor, and kidney of the host animals. These data suggest that some of the transfected miR-143BPs were secreted from THP-1 macrophages as MV-RNAs both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21102562      PMCID: PMC3034851          DOI: 10.1038/mt.2010.254

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  10 in total

1.  Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7.

Authors:  Veit Hornung; Margit Guenthner-Biller; Carole Bourquin; Andrea Ablasser; Martin Schlee; Satoshi Uematsu; Anne Noronha; Muthiah Manoharan; Shizuo Akira; Antonin de Fougerolles; Stefan Endres; Gunther Hartmann
Journal:  Nat Med       Date:  2005-02-20       Impact factor: 53.440

2.  Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo.

Authors:  Adam D Judge; Gurneet Bola; Amy C H Lee; Ian MacLachlan
Journal:  Mol Ther       Date:  2005-12-15       Impact factor: 11.454

3.  Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA.

Authors:  Adam D Judge; Vandana Sood; Janet R Shaw; Dianne Fang; Kevin McClintock; Ian MacLachlan
Journal:  Nat Biotechnol       Date:  2005-03-20       Impact factor: 54.908

Review 4.  Current status of polymeric gene delivery systems.

Authors:  Tae Gwan Park; Ji Hoon Jeong; Sung Wan Kim
Journal:  Adv Drug Deliv Rev       Date:  2006-06-15       Impact factor: 15.470

5.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

Review 6.  Shedding microvesicles: artefacts no more.

Authors:  Emanuele Cocucci; Gabriella Racchetti; Jacopo Meldolesi
Journal:  Trends Cell Biol       Date:  2009-01-12       Impact factor: 20.808

7.  Monocyte-derived microparticles and exosomes induce procoagulant and apoptotic effects on endothelial cells.

Authors:  Anat Aharon; Tal Tamari; Benjamin Brenner
Journal:  Thromb Haemost       Date:  2008-11       Impact factor: 5.249

8.  Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates.

Authors:  Maria Frank-Kamenetsky; Aldo Grefhorst; Norma N Anderson; Timothy S Racie; Birgit Bramlage; Akin Akinc; David Butler; Klaus Charisse; Robert Dorkin; Yupeng Fan; Christina Gamba-Vitalo; Philipp Hadwiger; Muthusamy Jayaraman; Matthias John; K Narayanannair Jayaprakash; Martin Maier; Lubomir Nechev; Kallanthottathil G Rajeev; Timothy Read; Ingo Röhl; Jürgen Soutschek; Pamela Tan; Jamie Wong; Gang Wang; Tracy Zimmermann; Antonin de Fougerolles; Hans-Peter Vornlocher; Robert Langer; Daniel G Anderson; Muthiah Manoharan; Victor Koteliansky; Jay D Horton; Kevin Fitzgerald
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-11       Impact factor: 11.205

9.  Downregulation of microRNAs-143 and -145 in B-cell malignancies.

Authors:  Yukihiro Akao; Yoshihito Nakagawa; Yukio Kitade; Tomohiro Kinoshita; Tomoki Naoe
Journal:  Cancer Sci       Date:  2007-09-24       Impact factor: 6.716

10.  Role of anti-oncomirs miR-143 and -145 in human colorectal tumors.

Authors:  Y Akao; Y Nakagawa; I Hirata; A Iio; T Itoh; K Kojima; R Nakashima; Y Kitade; T Naoe
Journal:  Cancer Gene Ther       Date:  2010-01-22       Impact factor: 5.987

  10 in total
  95 in total

1.  Plasma miR-451 with echocardiography serves as a diagnostic reference for pulmonary hypertension.

Authors:  Xiao-Wei Song; Lu-Lu Zou; Ling Cui; Song-Hua Li; Yong-Wen Qin; Xian-Xian Zhao; Qing Jing
Journal:  Acta Pharmacol Sin       Date:  2018-05-24       Impact factor: 6.150

2.  Stabilization of exosome-targeting peptides via engineered glycosylation.

Authors:  Michelle E Hung; Joshua N Leonard
Journal:  J Biol Chem       Date:  2015-02-05       Impact factor: 5.157

Review 3.  Extracellular microRNA profiling in human follicular fluid: new biomarkers in female reproductive potential.

Authors:  Maryam Qasemi; Fardin Amidi
Journal:  J Assist Reprod Genet       Date:  2020-07-09       Impact factor: 3.412

4.  Functional Delivery of Lipid-Conjugated siRNA by Extracellular Vesicles.

Authors:  Aisling J O'Loughlin; Imre Mäger; Olivier G de Jong; Miguel A Varela; Raymond M Schiffelers; Samir El Andaloussi; Matthew J A Wood; Pieter Vader
Journal:  Mol Ther       Date:  2017-04-06       Impact factor: 11.454

Review 5.  Exosomes and their Application in Biomedical Field: Difficulties and Advantages.

Authors:  Jafar Rezaie; Saeed Ajezi; Çığır Biray Avci; Mohammad Karimipour; Mohammad Hossein Geranmayeh; Alireza Nourazarian; Emel Sokullu; Aysa Rezabakhsh; Reza Rahbarghazi
Journal:  Mol Neurobiol       Date:  2017-05-11       Impact factor: 5.590

Review 6.  Extracellular vesicles for nucleic acid delivery: progress and prospects for safe RNA-based gene therapy.

Authors:  L Jiang; P Vader; R M Schiffelers
Journal:  Gene Ther       Date:  2017-01-31       Impact factor: 5.250

7.  The Potential of Exosomes From Cow Milk for Oral Delivery.

Authors:  Jamie L Betker; Brittany M Angle; Michael W Graner; Thomas J Anchordoquy
Journal:  J Pharm Sci       Date:  2018-11-20       Impact factor: 3.534

Review 8.  Achieving the Promise of Therapeutic Extracellular Vesicles: The Devil is in Details of Therapeutic Loading.

Authors:  Dhruvitkumar S Sutaria; Mohamed Badawi; Mitch A Phelps; Thomas D Schmittgen
Journal:  Pharm Res       Date:  2017-03-17       Impact factor: 4.200

Review 9.  Extracellular vesicles: biology and emerging therapeutic opportunities.

Authors:  Samir EL Andaloussi; Imre Mäger; Xandra O Breakefield; Matthew J A Wood
Journal:  Nat Rev Drug Discov       Date:  2013-04-15       Impact factor: 84.694

10.  Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells.

Authors:  Shin-ichiro Ohno; Masakatsu Takanashi; Katsuko Sudo; Shinobu Ueda; Akio Ishikawa; Nagahisa Matsuyama; Koji Fujita; Takayuki Mizutani; Tadaaki Ohgi; Takahiro Ochiya; Noriko Gotoh; Masahiko Kuroda
Journal:  Mol Ther       Date:  2012-10-02       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.